MicroRNA‐221 promotes breast cancer resistance to adriamycin via modulation of PTEN/Akt/mTOR signaling
2020 · Cancer Medicine · 46 citations
https://doi.org/10.1002/cam4.2817
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
27
Papers
351
Citations
9
h-index
6
i10-index
Hongmei Han is an academic researcher from Yanbian University Hospital. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Circular RNAs in diseases & MicroRNA in disease regulation. The author has an h-index of 9, co-authored 23 publications.
ORCID: 0000-0001-7147-4447https://doi.org/10.1002/cam4.2817
https://doi.org/10.1186/s12864-021-07984-6
Click to start Chat